EDEN PRAIRIE, Minn. , April 16, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced increased utilization of its Aquadex therapy in patients affected by COVID-19.
Citing Risk of Acute Kidney Injury, April 10th Physician-led Webinar Presented Real World Case Studies on Patients with COVID-19 EDEN PRAIRIE, Minn. , April 14, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from
EDEN PRAIRIE, Minn. , April 09, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for an adaptation to the Aquadex SmartFlow™ system to
EDEN PRAIRIE, Minn. , April 08, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, clinician-led webinar to discuss cardio-pulmonary-renal
EDEN PRAIRIE, Minn. , April 02, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced that it has doubled the production staff that builds its next generation Aquadex SmartFlow consoles in
EDEN PRAIRIE, Minn. , March 30, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 5,130,228 shares of its common stock at a price to the public of $0.434 per share, for gross proceeds of approximately $2,226,000 , prior to deduction
Company increases production in response to expected demand EDEN PRAIRIE, Minn. , March 25, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced the use of its Aquadex therapy in the
EDEN PRAIRIE, Minn. , March 20, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 4,161,392 shares of its common stock at a price to the public of $0.30 per share, for gross proceeds of approximately $1,248,000 , prior to deduction
EDEN PRAIRIE, Minn. , March 19, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the Aquadex FlexFlow system has been licensed and approved for sale in India , making ultrafiltration therapy available for patients suffering from hypervolemia, or fluid overload, in one of the
Proper Control of Fluids Routinely Administered to Patients with Acute Respiratory Infections Play Important Role in Successful Outcomes EDEN PRAIRIE, Minn. , March 18, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients